Macrogenics Inc
(NAS:MGNX)
$
4.36
0.25 (6.07%)
Market Cap: 273.08 Mil
Enterprise Value: 107.83 Mil
PE Ratio: 0
PB Ratio: 2.57
GF Score: 60/100 - Q4 2023 MacroGenics Inc Earnings Call TranscriptMar 07, 2024$20.51 (-4.47%)Earnings
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 MacroGenics Inc Earnings Call TranscriptNov 06, 2023$5.44 (+2.45%)Earnings
- MacroGenics Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 MacroGenics Inc Earnings Call TranscriptAug 09, 2023$4.98 (+1.84%)Earnings
- Q1 2023 MacroGenics Inc Earnings Call TranscriptMay 09, 2023$7.18 (-0.83%)Earnings
- MacroGenics Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 MacroGenics Inc Earnings Call TranscriptMar 15, 2023$6.34 (-1.71%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 MacroGenics Inc Earnings Call TranscriptNov 03, 2022$4.84 (-0.21%)Earnings
- Zymeworks Inc and MacroGenics Inc at Citi BioPharma Conference - Co Panel: Bispecific Panel TranscriptSep 07, 2022
- Q2 2022 MacroGenics Inc Earnings Call TranscriptAug 08, 2022$4.55 (+3.64%)Earnings
- MacroGenics Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 MacroGenics Inc Earnings Call TranscriptMay 03, 2022$7.75 (+2.11%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 MacroGenics Inc Earnings Call TranscriptFeb 24, 2022$10.49 (+4.59%)Earnings
- MacroGenics Inc at Citi Immuno-Oncology Summit (Virtual) TranscriptFeb 17, 2022
- MacroGenics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- MacroGenics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 MacroGenics Inc Earnings Call TranscriptNov 02, 2021$20.48 (-1.59%)Earnings
- MacroGenics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- MacroGenics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 MacroGenics Inc Earnings Call TranscriptJul 29, 2021$26.08 (-1.25%)Earnings
- MacroGenics Inc to Discuss the Preliminary MGC018 Results Conference Call TranscriptJun 04, 2021
- Q1 2021 MacroGenics Inc Earnings Call TranscriptApr 29, 2021$35.63 (+0.96%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 MacroGenics Inc Earnings Call TranscriptFeb 25, 2021$21.88 (+3.84%)Earnings
- MacroGenics Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- MacroGenics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- MacroGenics Inc to Discuss MARGENZAâ„¢ Approval - Conference Call TranscriptDec 17, 2020
- MacroGenics Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- MacroGenics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q3 2020 MacroGenics Inc Earnings Call TranscriptNov 04, 2020$21.06 (+5.25%)Earnings
- MacroGenics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- MacroGenics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 MacroGenics Inc Earnings Call TranscriptJul 30, 2020$26.75 (+3.72%)Earnings
- MacroGenics Inc ASCO 2020 Conference Call TranscriptMay 29, 2020
- Q1 2020 MacroGenics Inc Earnings Call TranscriptMay 05, 2020$7.6 (+6.29%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- MacroGenics Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 MacroGenics Inc Earnings Call TranscriptFeb 25, 2020$10.99 (-0.72%)Earnings
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- MacroGenics Inc to Review Flotetuzumab Data Presented at the ASH Annual Meeting - Call TranscriptDec 10, 2019
- MacroGenics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 MacroGenics Inc Earnings Call TranscriptNov 06, 2019$8.37 (-1.53%)Earnings
- MacroGenics Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- MacroGenics Inc at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 MacroGenics Inc Earnings Call TranscriptJul 31, 2019$14.39 (-2.18%)Earnings
- MacroGenics Inc at American Society of Clinical Oncology Conference Call TranscriptJun 04, 2019
- Q1 2019 MacroGenics Inc Earnings Call TranscriptMay 01, 2019$16.78 (+0.06%)Earnings
- Q4 2018 MacroGenics Inc Earnings Call TranscriptFeb 26, 2019$20.84 (-4.10%)Earnings
MacroGenics Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022 / 07:50PM GMT
Release Date Price:
$8.21
(+1.11%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
So first and foremost, thanks for everybody attending. It's the first conference in a couple of years we're back to in person. So thanks for the enthusiasm and support. And thank you so much, Scott, for attending and all your time.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Always a pleasure.
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
Always a pleasure to chat with you.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Same here.
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
We've only got 25 minutes though. That's the only...
Scott Koenig;Peter Richard Lawson
MacroGenics, Inc. - CEO, President & Director;
Absolutely. So you only get to ask one question, I think.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)